The effects of a specific alpha(2)-adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats.

[1]  J. Sirviö,et al.  Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  M. Millan,et al.  Actions of α2 adrenoceptor ligands at α2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for α2A adrenoceptors , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  R. Lammintausta,et al.  Facilitation of cognitive functions by a specific alpha2-adrenoceptor antagonist, atipamezole. , 1998, European journal of pharmacology.

[4]  M. Yoshioka,et al.  Effects of idazoxan on dopamine release in the prefrontal cortex of freely moving rats. , 1998, European journal of pharmacology.

[5]  L. Tuomisto,et al.  Evaluation of the effects of a specific α2-adrenoceptor antagonist, atipamezole, on α1- and α2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  R. Huupponen,et al.  Anti-obesity effect of MPV-1743 A III, a novel imidazoline derivative, in genetic obesity. , 1997, European Journal of Pharmacology.

[7]  J. Muir,et al.  Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease , 1997, Behavioural Brain Research.

[8]  F. Colpaert,et al.  Acetylcholine Release in the Rat Prefrontal Cortex In Vivo: Modulation by α2‐Adrenoceptor Agonists and Antagonists , 1997, Journal of neurochemistry.

[9]  Á. Pazos,et al.  The subtype-selective α2-adrenoceptor antagonists BRL 44408 and ARC 239 also recognize 5-HT1A receptors in the rat brain , 1996 .

[10]  M. Bunsey,et al.  Specific effects of idazoxan in a distraction task: evidence that endogenous norepinephrine plays a role in selective attention in rats. , 1995, Behavioral neuroscience.

[11]  G. Ordway.  Effect of Noradrenergic Lesions on Subtypes of α2‐Adrenoceptors in Rat Brain , 1995 .

[12]  S. Sara,et al.  Locus coeruleus-evoked responses in behaving rats: A clue to the role of noradrenaline in memory , 1994, Brain Research Bulletin.

[13]  E. Vizi,et al.  Differential changes in presynaptic modulation of transmitter release during aging , 1994, International Journal of Developmental Neuroscience.

[14]  H. Lahtinen,et al.  Spatial Learning and Noradrenaline Content in the Brain and Periphery of Young and Aged Rats , 1994, Experimental Neurology.

[15]  A. Arnsten,et al.  Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: Indirect effects of yohimbine versus direct effects of clonidine , 1993, Neurobiology of Aging.

[16]  S. Foote,et al.  Noradrenergic modulation of cognitive function: clinical implications of anatomical, electrophysiological and behavioural studies in animal models , 1993, Psychological Medicine.

[17]  P. Jäkälä,et al.  Dose- and parameter-dependent effects of atipamezole, an α 2-antagonist, on the performance of rats in a five-choice serial reaction time task , 1993, Pharmacology Biochemistry and Behavior.

[18]  C. Mathis,et al.  Quantitative in vitro and ex vivo autoradiography of the α2-adrenoceptor antagonist [3H]atopamezole , 1992 .

[19]  J. C. Winter,et al.  Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. , 1992, The Journal of pharmacology and experimental therapeutics.

[20]  Á. Díaz,et al.  Regionally specific age-dependent decline in α 2-adrenoceptors: An autoradiographic study in human brain , 1991, Neuroscience Letters.

[21]  R. Kalaria,et al.  Adrenergic receptors in aging and Alzheimer's disease: Decreased α2-receptors demonstrated by [3 H]p-aminoclonidine binding in prefrontal cortex , 1991, Neurobiology of Aging.

[22]  J L McGaugh,et al.  The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory , 1991, Synapse.

[23]  G. Buzsáki,et al.  Spike-and-wave neocortical patterns in rats: Genetic and aminergic control , 1990, Neuroscience.

[24]  V. Luine,et al.  Spatial memory deficits in aged rats: contributions of monoaminergic systems , 1990, Brain Research.

[25]  S. Sara,et al.  Activation of the noradrenergic system facilitates an attentional shift in the rat , 1990, Behavioural Brain Research.

[26]  T. Pugsley,et al.  Loss of muscarinic M1 receptors with aging in the cerebral cortex of fisher 344 rats , 1990, Pharmacology Biochemistry and Behavior.

[27]  W. Mcentee,et al.  Age‐associated memory impairment , 1990, Neurology.

[28]  J. Schwartz,et al.  Modulation of Histamine Release and Synthesis in the Brain Mediated by α2‐Adrenoceptors , 1989 .

[29]  S. Sara,et al.  Idazoxan, an α-2 antagonist, facilitates memory retrieval in the rat , 1989 .

[30]  J. Rinne,et al.  Different forms of brain acetylcholinesterase and muscarinic binding in Parkinson's disease , 1989, Journal of the Neurological Sciences.

[31]  M. Scheinin,et al.  Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative. , 1988, European journal of pharmacology.

[32]  M. Scheinin,et al.  Behavioural and neurochemical effects of atipamezole, a novel α2-adreneceptor antagonist , 1988 .

[33]  Y. Nomura,et al.  Age related changes in the inhibitory effect of clonidine on high K+-evoked noradrenaline release from brain slices of rats. , 1988, Journal of pharmacobio-dynamics.

[34]  D. Gash,et al.  Transplantation of norepinephrine neurons into aged rats improves performance of a learned task , 1988, Brain Research.

[35]  Carolyn W. Harley,et al.  A role for norepinephrine in arousal, emotion and learning?: Limbic modulation by norepinephrine and the kety hypothesis , 1987, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[36]  M. Decker.  The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system , 1987, Brain Research Reviews.

[37]  J. Weiss,et al.  Alpha-2 receptor blockade increases responsiveness of locus coeruleus neurons to excitatory stimulation , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  S. Zornetzer.  Catecholamine System Involvement in Age‐related Memory Dysfunction , 1985, Annals of the New York Academy of Sciences.

[39]  P. Waldmeier,et al.  Alteration of central alpha2- and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin , 1983, Neuroscience.

[40]  P. Meyer,et al.  α1- and α2-adrenoceptors in rat cerebral cortex: Effects of neonatal treatment with 6-hydroxydopamine , 1982 .

[41]  R. Iman,et al.  Rank Transformations as a Bridge between Parametric and Nonparametric Statistics , 1981 .

[42]  G. Aghajanian,et al.  Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. , 1977, European journal of pharmacology.

[43]  F. Fonnum,et al.  A rapid radiochemical method for the determination of choline acetyltransferase , 1975, Journal of neurochemistry.

[44]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[45]  K. Jellinger.  Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms? , 1999, Journal of neural transmission. Supplementum.

[46]  A. Haapalinna,et al.  Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. , 1997, Behavioural brain research.

[47]  O. Pompeiano,et al.  Neurobiology of the locus coeruleus , 1991 .

[48]  G. Aston-Jones,et al.  Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. , 1991, Progress in brain research.

[49]  J. Savola,et al.  Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole. , 1989, Archives internationales de pharmacodynamie et de therapie.

[50]  S. Tanganelli,et al.  Noradrenergic modulation of cortical acetylcholine release is both direct and gamma-aminobutyric acid-mediated. , 1986, The Journal of pharmacology and experimental therapeutics.